Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 13, 1999

View Archived Issues

ID Biomedical initiates phase I trials of GAS vaccine

Ixion Biotechnology awarded NIH grant for type I diabetes research

Licensing opportunity from NIH: gene therapy for chronic or persistent pain

Licensing opportunity from NIH: cyanovirin N-based topical microbicides active against HIV

Nonpeptide modulators of GnRH release patented by Alanex

New triazole antifungal agents developed at Roche

Selective ligands for 5-ht6 receptors from Roche useful for CNS disorders

Pfizer's new macrolides described in recent patent literature

HMR prepares potassium channel blockers for arrhythmias, etc.

Emory U. develops metal chelates for renal imaging with advantageous properties

Two new photoactivatable, biotin-labeled verapamil analogues useful for studies on P-170

Positive phase I/II reported for Nuvance at European meeting

Clinical results presented at ICAAC demonstrate equivalence of Twinrix to two monovalent vaccines

Viral load significantly reduced by addition of T-20 in heavily pretreated HIV-infected patients

Herpes simplex L.E.A.P.S. vaccine is protective in animal models

Pleconaril now shown to be effective in adolescents and adults with enteroviral meningitis

DHA: a new treatment for CF on the horizon?

SU-5416: promising phase I findings presented at ICAAC; update on clinical status

PDE3 inhibitor olprinone is an effective bronchodilator in asthma patients

Glaxo Wellcome receives approval in Germany for Flixotide in COPD

News from ERS: tiotropium prevents methacholine-induced bronchoconstriction in asthmatics

Resistance profile of DAPD elucidated in vitro

Panel recommends Pfizer's Zoloft for Rx of posttraumatic stress disorder

ImClone Systems initiates enrollment in phase II C225/CPT-11 trial

Preclinical, early clinical results indicate good efficacy and safety of D-4418

DuPont acquires ImaRx

Antimetastatic activity demonstrated for new MAb in breast cancer-bearing mice

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...